These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3022759)

  • 1. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis.
    Christensen ML; Pachman LM; Schneiderman R; Patel DC; Friedman JM
    Arthritis Rheum; 1986 Nov; 29(11):1365-70. PubMed ID: 3022759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis.
    Pachman LM; Hayford JR; Hochberg MC; Pallansch MA; Chung A; Daugherty CD; Athreya BH; Bowyer SL; Fink CW; Gewanter HL; Jerath R; Lang BA; Szer IS; Sinacore J; Christensen ML; Dyer AR
    Arthritis Rheum; 1997 Aug; 40(8):1526-33. PubMed ID: 9259435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological study of idiopathic cardiomyopathy: serological study of virus antibodies and immunofluorescent study of myocardial biopsies.
    Kitaura Y
    Jpn Circ J; 1981 Mar; 45(3):279-94. PubMed ID: 6259384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.
    King ML; Shaikh A; Bidwell D; Voller A; Banatvala JE
    Lancet; 1983 Jun; 1(8339):1397-9. PubMed ID: 6134178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neutralizing antibodies to Coxsackie virus group B 1986-1988].
    Kuljić-Kapulica N; Zivanović-Marinković V; Krstić L; Nozić M; Budisin A
    Vojnosanit Pregl; 1990; 47(4):294-6. PubMed ID: 2173272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes and Coxsackie virus infection.
    Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
    Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackievirus infection and the development of polymyositis/dermatomyositis.
    Nishikai M
    Rheumatol Int; 1994; 14(2):43-6. PubMed ID: 7824834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and neonatal neutralizing antibody titers to selected enteroviruses.
    Hammond GW; Lukes H; Wells B; Thompson L; Low DE; Cheang M
    Pediatr Infect Dis; 1985; 4(1):32-5. PubMed ID: 2982132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.
    Banatvala JE; Bryant J; Schernthaner G; Borkenstein M; Schober E; Brown D; De Silva LM; Menser MA; Silink M
    Lancet; 1985 Jun; 1(8443):1409-12. PubMed ID: 2861361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel.
    Morag A; Margalith M; Shuval HI; Fattal B
    J Med Virol; 1984; 14(1):39-47. PubMed ID: 6747611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective.
    Sassetti C; Borrelli C; Mazuy M; Turrini I; Rigante D; Esposito S
    Front Immunol; 2024; 15():1377952. PubMed ID: 38660309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes.
    Mertens T; Grüneklee D; Eggers HJ
    Eur J Pediatr; 1983 Sep; 140(4):293-4. PubMed ID: 6313373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of coxsackie B antibodies during juvenile diabetes.
    Schmidt WA; Brade L; Müntefering H; Klein M
    Med Microbiol Immunol; 1978; 164(4):291-8. PubMed ID: 45604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackie virus infection in association with heart affection in man.
    Petrovicová A; Cervenka J; Egnerová A
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):251-7. PubMed ID: 2824602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases.
    El-Hagrassy MM; Banatvala JE; Coltart DJ
    Lancet; 1980 Nov; 2(8205):1160-2. PubMed ID: 6107769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective study of coxsackie B virus infections and congestive cardiomyopathy].
    Campello C; Dal Molin G; Gasparini V; Mestroni L; Salvi A; Camerini F; Majori L
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):325-30. PubMed ID: 6097290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis, polymyositis, and Coxsackie-B-virus infection.
    Bowles NE; Dubowitz V; Sewry CA; Archard LC
    Lancet; 1987 May; 1(8540):1004-7. PubMed ID: 2883345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria.
    Ijaola O; Falase AO
    Afr J Med Med Sci; 1990 Jun; 19(2):93-103. PubMed ID: 2165348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.